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Abstract. 
Conjugated linoleic acid (CLA) is produced in the rumen by isomerization 
of linoleic acid and has been shown to be anticarcinogenic. The objective of this 
study was to determine the effects of feeding dietary CLA to pre-ruminant lambs 
or linoleic acid-rich safflower oil to weaned ruminating lambs. Fat content, CLA 
content and fatty acid (FA) composition of diaphragm, leg, rib, subcutaneous 
(SC) adipose and liver tissues were determined. The triacylglycerol (TAG) 
fractions of the total lipid (TL) from the diaphragm, rib and SC adipose tissues 
were analyzed for FA composition and FA positional distribution. The 
phospholipid (PL) fractions of the TL were analyzed for FA composition. The 
positional distribution of FAs of liver PL was determined. Tissue fat content was 
affected by diet only in SC adipose tissue. Dietary supplementation with 
safflower oil increased the fat content of the subcutaneous adipose tissue 
whereas CLA supplementation resulted in decreased (P<0.05) fat content. 
Dietary supplementation with safflower oil increased (P<0.05) the CLA content of 
tissues by more than 200% whereas dietary supplementation with CLA did not 
affect CLA content. Positional distribution analysis indicated that CLA tends was 
localized to the sn-1/3 positions of TAG and the sn-2 position of the liver PL. 
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1 . Introduction. 
Conjugated linoleic acid (CLA) is a unique fatty acid with health enhancing 
properties. CLA was first identified in the 1960s as an intermediate in the 
breakdown of linoleic acid by bacteria in the rumen. The discovery of CLA as an 
anticarcinogenic compound in the 1980s resulted in intense studies of the 
distribution of this fatty acid (FA) in food and research into the anticarcinogenic 
properties it possesses. CLA has been found in almost every food examined to 
greater or lesser extents but is particularly abundant in foods of ruminant origin 
such as milk, cheese and meat. In fact, it was initially isolated from fried ground 
beef as an anticarcinogenic compound by Ha and co-workers in 1987. Health 
conscious consumers are eating less beef and drinking less whole milk in an 
effort to reduce dietary saturated fat. In doing so they are depriving themselves 
of beneficial CLA. The health enhancing properties of CLA that have been 
promoted over the last ten years include cancer prevention and treatment, 
enhancement of the immune response, cholesterol reduction and potential as a 
weight reduction agent. For example, CLA does inhibit some kinds of 
tumorigenesis when incorporated in the diet of rodents or applied exogenously to 
cell culture. There has also been evidence in pigs and rodents that it can act as a 
fat to lean partitioning factor resulting in reduced fat deposition and enhanced 
growth. The positive attributes of CLA have resulted in the production and 
marketing of encapsulated CLA as a health supplement. 
Experimental evidence shows that levels of CLA in beef and other 
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ruminant food products can be manipulated by dietary regime. CLA levels in milk 
and beef of grass fed animals are higher than those found non-grass fed 
animals. This is due to the higher levels of linoleic acid (LA) found in most 
grasses compared to grains. This can be overcome by supplementing the diets 
of cattle with a high LA oil thus providing the precursor of CLA to the rumen 
bacteria for conversion into CLA and subsequent incorporation into meat and 
milk fat. Although CLA is known to be present in ruminant tissues and products, 
little work has been done on the enhancement of CLA content as a natural 
product of simple dietary manipulation in meat animals or its deposition in tissues 
due to such manipulations. This thesis examines the effect of including pre­
formed CLA in the diet of pre-ruminant lambs (Ow's aries) or including LA in the 
diet of ruminating lambs as a means of increasing the CLA content of the 
carcass. The positional distribution of CLA in triacylglycerols from muscle and 
subcutaneous fat tissue was examined under both dietary regimes in order to 
gain some insight into the mechanism of CLA incorporation into the acylglycerols 
of the ruminant tissues. The CLA content of phospholipid (PL) from these tissues 
was also examined. The positional distribution of CLA in the liver PL fraction of 
the lambs was examined for comparative purposes. 
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2. Literature Review. 
2.1. Conjugated Linoleic Acid (CLA) 
2.1.1. CLA as an Anticarcinoaen 
Conjugated linoleic acid (CLA) is a form of linoleic acid (LA) (C18:2, c/s-
9,c/'s-12) containing a conjugated double bond system. LA has a c/s double bond 
at carbons 9 and 12 (Figure 1). When a single bond is present between two 
double bonds of the acyl chain it is known as the conjugated form. CLA has a 
double bond at positions 9 and 11, or 10 and 12 (Ha ef a/., 1987). The c/s-9, 
1 isomer of CLA is depicted in Figure 1. 
CLA was first identified as an anticarcinogen in extracts from fried ground 
beef (Ha era/., 1987). Extracts from fried ground beef were found to contain 
mutagenesis modulator activity that inhibited rat liver S-9 mediated mutagenesis 
(Pariza eta/., 1983; Pariza era/., 1985). Partially purified extracts from fried 
gound beef that contained this modulator activity also inhibited 7,12-
dimethylbenz[a]anthracene (DMBA) initiation of mouse epidermal 
carcinogenesis. Through the use of semi-preparatory high performance liquid 
chromatography (HPLC) the anticarcinogenic fraction was purified and 
subsequently identified as geometric isomers of LA containing a conjugated 
double bond system. CLA synthesized in the laboratory was identical to the 
purified anticarcinogenic fraction as identified by gas chromatography (GC), 
ultraviolet (UV) spectroscopy and nuclear magnetic resonance (NMR) analysis 
(Ha ef a/., 1987). 
Linoleic Acid. 
Figure 1: Molecular structures of linoleic acid and c/s 9, trans 11 conjugated 
linoleic acid, red: oxygen, dark grey: carbon, light grey: hydrogen. 
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There have been numerous studies into the effects of synthetic CLA on 
tumorigenesis when applied exogenously or included as part of the diet. When 
topically applied prior to DMBA treatment, CLA is also able to inhibit initiation of 
mouse epidermal tumors. Dietary CLA has been shown to inhibit promotion of 
skin tumors when included in the diet after initiation with DMBA but before 
promotion with 12-0-tetradecanoylphorbol-13-acetate (TPA) (Belury era/., 1996). 
Mouse stomach neoplasia induced by benzo(a)pyrene (BP) and colon 
carcinogenesis induced by 2-amino-3-methylimidazo[4,5-/l quinoline (IQ) (a 
heterocyclic amine carcinogen found in grilled ground beef) in F344 rats were 
both inhibited by CLA administered by gavage prior to and concomitant with 
either BP or IQ treatment (Ha etai, 1990; Liew etai, 1995). Mammary 
carcinogenesis induced by DMBA was suppressed by dietary CLA, as a free acid 
at levels of 1.0 and 1.5% in the diet, when started 2 weeks prior to DMBA 
treatment (Ip etai., 1991). When 1.0% CLA was supplied as a dietary 
component, either as a free acid or triacylglycerol (TAG), during the post-
weaning and pubertal stages of rats (21 days) and prior to administration of the 
tumorifgenic compound methylnitrosourea (MNU) tumorigenesis was reduced. 
CLA has also been shown to inhibit MNU induced tumorigenesis when 
administered after MNU treatment, but a continuous intake of CLA was 
necessary for maximal and lasting inhibition (Ip etai, 1995). Additionally, dietary 
CLA has been shown to have an hypocholesterolemic and antiatherogenic effect 
in rabbits (Lee etai, 1994). 
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2.1.2. CLA as an Antioxidant 
The antioxidant activity of CLA has been offered as a possible explanation 
of the anticarcinogenic and antiatherosclerotic properties of CLA. The 
antioxidant potential of CLA was compared with known antioxidants using the 
thiocyanate method. In this test using free fatty acids (FAs) in a phosphate buffer 
and ethanol mixture the degree of LA oxidation was determined by the addition of 
ferrous ammonium sulfate and thiocyanate then followed by absorbance 
determinations at 480nm. CLA was found to be more powerful than a-tocopherol 
and comparable to butylated hydroxytoluene (BHT) as an antioxidant in vitro (Ha 
etai, 1990). Antioxidant activity of CLA in vivo was reported by Ip ef a/ (1991). 
Mammary and liver tissue from rats fed either CLA, vitamin E or butylated 
hydroxyanisole (BHA) were tested for thiobarbituric-acid (TBA) reactive 
substances that are presumably lipid peroxidation products. Results of this study 
showed that CLA decreased the amount of TBA reactive substances detected in 
mammary tissue but had no effect on the amount present in liver tissue. 
Subsequent work by van den Berg et al (1995) disputed the claim of antioxidant 
activity of CLA measured by these methods, stating that the conditions of the 
thiocyanate method are very dissimilar to biological systems and that the TBA 
assay is known to be indirect and not specific. They indicated in their tests, using 
a model system of phospholipid (PL) membranes subjected to various types of 
oxidative stress, that CLA was insufficiently reactive toward radicals in 
comparison to a-tocopherol and BHT for it's mode of action to be that of a radical 
scavenger 
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2.1.3. CLA as a Growth Factor 
Chronic CLA feeding has been shown to have no effect on animal growth 
rate (Ip et al, 1991). Observations that CLA was able to reduce catabolism of 
skeletal muscles after immune stimulation in mice, rats and chickens (Cooke et 
al., 1993; Miller et al., 1994) led to the hypothesis that CLA may function as a 
growth factor by reducing catabolism of skeletal muscle which reduces the 
energy available for growth, thus functioning as an energy partitioning agent. 
While consumption of CLA had no effect on food intake or weight gain of rat 
dams during gestation, dietary CLA at levels of 0.5% for dams resulted in 
significantly higher pup weight at ten days of age compared to pups of dams 
receiving control diets or 0.25% CLA during gestation and lactation. Pups from 
dams that received 0.5% CLA only during lactation were of intermediate weight 
(Chin ef al., 1994b). CLA (0.5%) in the diets of male mice for 32 days post 
weaning and female mice for 28 days post-weaning resulted in a reduction in 
percent body fat by 57% and 60% respectively (Park ef al., 1997). Whole body 
weights of control and treatment groups showed no significant differences (Park 
ef a/., 1997). In the same study, it was determined that percent protein and 
percent water in the treatment animals was significantly enhanced compared to 
controls. 
The desire of the meat industry to produce animals with improved lean 
production efficiency has prompted research into the value of feeding CLA to 
meat animals. Feeding a diet containing CLA to pigs has produced animals with 
an overall increased gain to feed ratio and lean tissue depostion and reduced 
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subcutaneous fat (SC) deposition (Dugan etai., 1997; Ostowska era/., 1999). 
2.1.4. Action and Metabolism of CLA 
The actual mechanism of CLA action is poorly understood. CLA is 
relatively stable (does not oxidize) when exposed to air at room temperature (Ha 
ef al., 1987) compared to the level of oxidation of LA. CLA also exhibits 
antioxidant activity, inhibiting peroxide formation that is higher by 90% or more of 
the levels inhibited by a-tocopherol (vitamin E) and to levels similar to that of 
BHT when assayed by the thiocyanate method at a molar ratio of 1 part CLA to 
100 parts LA in vitro (Ha ef al., 1990). Antioxidant activity, as evaluated by the 
TBA method, followed the effect of CLA feeding ranging from 0.25% to 1.5% in 
the diet. The amount of TBA reactive substances (lipoperoxidation products) 
detected in liver did not change but there was a significant decrease in these 
substances in the mammary gland (Ip etai., 1991). 
Despite the previous evidence that CLA can act as an antioxidant in vivo 
(Ip ef al., 1991) and in vitro (Ha etai., 1990), investigations into the mechanism 
of CLA's anticarcinogenic effect provide evidence that CLA actually increases 
lipid peroxidation in some cultured cell lines. Human lung carcinoma cell lines, 
A4-27, SK-LU-1 and A549 showed a dose and time dependent growth inhibition 
with CLA. Addition of a-tocopherol (a known antioxidant) to the growth medium 
resulted in partial growth recovery of these cell lines. Levels of lipid peroxidation 
products, as identified by the TBA method, were several fold higher in the CLA 
cultures than the control cultures (Schonberg and Krokan, 1995). 
CLA also appeared to inhibit cell growth in tissue culture. Schultz ef al. 
(1992) found a dose and time dependent inhibition of cell growth by CLA in the 
human MCF-7 breast cancer cell line that was more consistent than inhibition by 
LA at a bovine serum albumin concentration of 2.3 mg/ml. desBordes and Lea 
(1995) found that 100 mM LA inhibited thymidine incorporation more than CLA at 
the same concentration in the MCF-7 cell line, the 7800NJ rat heptoma cell line 
and T47D human breast cancer cells. CLA and LA, however exhibited similar 
inhibitory effects at concentrations of 500 mM. Increasing the concentration of 
albumin from 1 to 38 mg/ml greatly diminished the inhibitory effects of both CLA 
and LA at 500mM concentrations. 
In tests to determine if CLA could protect membranes composed of 1-
palmitoyl-2-linoleoyl-phosphatidylcholine from oxidation, CLA was less effective 
than a-tocopherol and BHT as a radical scavenging antioxidant (van den Berg ef 
a/., 1995). Tests of CLA's stability during the same study indicated that CLA was 
more susceptible to oxidation than LA. This was contrary to the results of Ha ef 
al. (1987). Four furan FAs have been identified as oxidation products of CLA by 
GC analysis. These are 8,11-epoxy-8,10-octadecadienoic acid (F 3 i 1 1); 9,12-
epoxy-9,11-octadecadienoic (F9,i2); 10,13-epoxy-10,12-octadecadienoic (Fi 0, 1 3) 
and 11,14-epoxy-11,13-octadecadienoic(Fii,u) (Yurawecz ef al., 1995). In 
determining the oxidation products of CLA, Yurawecz etai. (1995) found that 
CLA was very stable in methanol solutions containing 10% or less of water. 
Greater yields of furan FAs as oxidation products were associated with a more 
efficient suspension of CLA. Increasing water to 50% of the solution produced 
the maximum oxidation of CLA. 
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Other suggested modes of action of CLA's anticarcinogenic effects may 
be due it's ability to inhibit protein and nucleotide biosynthesis (Schultz et al., 
1992) prostaglandin E synthesis and ornithine decarboxylase activity (Liu and 
Belury, 1997); these events are strongly linked to skin tumor promotion. 
Conjugated forms of C 18:3 and C20:3 have been detected in rat liver and 
lamb liver which also contained conjugated forms of C20:4 (Banni ef al., 1996). 
These FAs were further characterized and identified as C20:3 A8,12,14; C20:4 
A5,8,12,14; C20:4 A5,8,11,13 (Sebedio ef al., 1997). These FAs likely arose 
from elongation and desaturation of C 18:2 A10.12 and C18:2 A9,11 (Sebedio ef 
al., 1997). 
2.15. CLA in Food 
Chin ef al. (1992) conducted an extensive survey of the presence and 
concentrations of CLA in various foodstuffs. This study indicated that the 
principal dietary sources of CLA were meat and dairy products. Meat from 
ruminants (beef, lamb) generally contained more CLA, ranging from 2.7 to 5.6 
mg CLA/g fat, than meat from nonruminants, such as chicken, pork and seafood, 
which had CLA concentrations of 0.3 to 0.9 mg CLA/g fat. Dairy products also 
showed high levels of CLA. Cow's milk contained 5.5 mg CLA/g fat. Cheeses 
contained from 2.9 to 7.1 mg CLA/g fat and yogurt ranging from 1.7 to 4.8 mg 
CLA/g fat. Oils from plants had a lower CLA content ranging from 0.1 to 0.7mg 
CLA/g fat whereas beef tallow had a CLA content of 2.6 mg CLA/g fat. 
The early work of Ha ef al (1987 and 1989) indicated that cooking of 
ground beef and the processing of cheese led to an increase in concentrations of 
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CLA. The postulated mechanism for this production of CLA was through the 
presence of a LA radical which interacted with hydrogen to form a double bond 
system. 
The food survey of Chin ef al. (1992) indicated that, in general, processing 
did not alter total CLA content on a mg CLA/g fat basis and that total CLA in 
canned foods was similar to that of comparable unprocessed foods. Similarly 
work of Shantha ef al (1994) indicated that different cooking methods such as 
frying, broiling, baking or microwaving did not result in any significant changes in 
the CLA content of ground beef when compared on a mg CLA/g fat basis. 
Cooking method and degree of doneness can affect the concentration of dietary 
CLA from beef products since cooking methods can influence total fat content. 
The varying concentrations of CLA in cheeses may be related to the CLA 
content of the starting product, milk. The CLA content of milk has been shown to 
be variable, ranging from 2.4 to 21.8 mg CLA/g fat (Riel, 1963). It was 
hypothesized that this may occur because of seasonal variations in pasture 
feeding practices (Shantha etai, 1995; Riel, 1963; Parodi, 1977) and diet (Chin 
etai., 1994a; Jiang etai., 1996; Kelleyef al., 1998). There is also evidence to 
indicate, however, that addition of whey protein concentrate (WPC) to processed 
cheese results in an increased CLA content, specifically addition of the low 
molecular weight fraction (LMW) of WPC. The CLA content in the processed 
cheese increased by 1.73mg/g fat. The maximum amount CLA content could 
have increased based on fat content of WPC alone would have been 0.016 mg/g 
fat. The ability of the WPC and whey LMW fraction to increase the formation of 
12 
CLA could have been due to interactions between components of the whey LMW 
fraction and LA radicals (Shantha etai, 1992). 
Processing of cheeses at temperatures greater than 80°C also increased 
the formation of CLA when the processing was done under atmospheric 
conditions. Processing under nitrogen has shown no such increases indicating 
that both temperature and the presence of air play a role in CLA formation. The 
ability of increased temperature and/or the presence of air may result in the 
formation of oxygen radicals and subsequently LA radicals, thus increasing CLA 
concentrations upon addition of hydrogen from protein sources to form the 
conjugated double bond system (Shantha ef al, 1992). 
Further work by Shantha ef al. (1995) on other dairy products indicated 
that total CLA concentrations in salted and unsalted butter increased 
approximately 1.3-fold from that of the starting material and that nonfat yogurt 
had more CLA than it's starting material. Conversely, work carried out by Werner 
ef al (1992) suggests that the use of different starter cultures, processing 
conditions and aging periods had a negligible effect on total CLA concentration. 
Work by Lin ef al (1995) concluded that activity of microbial metabolic reactions 
may be related to the differences in the CLA content of these products as well as 
the processing conditions. 
2.2. The Rumen 
2.2.1. Anatomy of the Rumen 
The ruminant stomach is a four-chambered organ that functions to digest 
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Figure 2. Cartoon of cow showing the relative positions of the rumen (R), 
omasum (0), and abomasum (A) in the ruminant digestive system. 
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the grains and forages eaten by ruminant animals (Van Soest, 1994). The four 
chambers are the rumen, reticulum (often referred to as the reticulorumen) 
omasum and abomasum (Figure 2). In young ruminants the rumen is 
undeveloped and suckled milk is bypassed to the abomasum due to closure of 
the esophageal groove during sucking and swallowing. Rumen development is 
stimulated by ingestion of solid feed and inoculation by rumen bacteria through 
feed and feces and contact with other animals. 
2.2.2. Digestion 
Food is initially masticated and mixed with saliva sufficiently to form a 
bolus that is swallowed and enters the anterior portion of the rumen (Van Soest, 
1994). The rumen represents a microbial population that facilitates the 
celluolytic, proteolytic and lipolytic breakdown of feedstuffs. The reticulorumen 
contracts and relaxes to mix the ingesta. Integrated with this process is 
rumination. Rumination is the regurgitation of ingesta to be remasticated to 
further reduce particle size and extract water-soluble contents with saliva from 
the initial feeding event. This integrated process allows for the selective turnover 
of indigestible food which can be regurgitated and masticated as many times as 
necessary. Fine particles and liquid will flow from the reticulorumen into the 
omasum through the reticulo-omasal orifice. The omasum functions to absorb 
water and nutrients with leaf like structures which can also block passage of any 
large particles of digesta, and to pump the digesta from the reticulum to the 
abomasum through the omasal canal and omasal-abomasal orifice. The 
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abomasum is the true stomach of the ruminant where gastric juices are secreted 
and peptic digestion takes place. This includes the digestion of microbial cells 
that arrive from the rumen by pepsin and lysozyme secretions. The now acidic 
digesta continue their flow out of the abomasum through the pylorus and into the 
duodenum where mixing with both biliary and pancreatic secretions facilitate 
homogenization of fats and hydrolysis of starch, proteins and TAGs. Most 
soluble starches and TAGs are broken down in the rumen and do not reach this 
stage of digestion. Nutrient absorption takes place in the small intestine. In the 
large intestine, the colon and caecum function to absorb electrolytes and water 
and break down any slow digesting feed that escapes from the reticulorumen. 
2.2.3. Lipid Metabolism in the Rumen: Lipolvsis and Biohvdroaenation 
There are two types of FAs. Saturated FAs have only single bonds in the 
acyl chain. Unsaturated FAs have at least one double bond present in the acyl 
chain. Unsaturated FAs can be further subdivided into cis and trans forms. The 
position of this bond affects the conformation of the individual FA. A cis bond will 
result in a bend in the acyl chain whereas a trans bond will result in a straight 
chain form like that of a saturated FA. 
Saturated FAs are considered undesirable and have been linked to 
coronary heart disease and cancer. Saturated FAs produce harder fats due to 
the ease of 'stacking' of the straight chain form. There are also possible risks 
perceived in the consumption of high levels of the unsaturated trans FAs due to 
their similarity in structure to saturated FAs. TAGs, containing unsaturated fatty 
acyl moeities, found primarily in plants are considered more desirable in the 
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human diet as they are softer. 
Hydrogenation is a process by which unsaturated FAs are converted to 
saturated FAs. This occurs during processing of vegetable oils to produce 
margarine that is soft but not liquid. In ruminant animals this is a natural process 
carried out by rumen microbes, and referred to as biohydrogenation. The 
unsaturated fats, LA and linolenic acid (C18:2 and C18:3) found in grains and 
forages respectively are bio-hydrogenated in a multi-step process from to the 
completely saturated form, stearic acid (C18:0). The trans form of (t-11)18:1 is 
an intermediate of this biohydrogenation process as is the c9,t11 isomer of LA 
known as CLA. 
Increasing intake of trans FAs at the expense of cis fats has been shown 
to increase plasma low density lipoprotein (LOL) cholesterol levels, raise 
lipoprotein (a) (Lp(a)) levels and lower high density lipoprotein (HDL) cholesterol 
levels. These results indicated that increased trans FA intake is unfavourable in 
view of increased cardiovascular disease risk (Zock and Katan, 1997, Precht and 
Molkentin, 1995). Trans FAs have not been shown, however, to increase cancer 
risk in animal model studies (Ip ef al, 1991) when increased at the expense of cis 
forms. 
Once lipids enter the rumen there are two important microbial 
transformations that take place; lipolysis of esterified plant lipids is followed by 
biohydrogenation of the free FAs produced to reduce the number of double 
bonds (Jenkins, 1993). Biohydrogenation in the rumen ultimately results in 
formation of saturated FAs from unsaturated FAs. Intermediate forms of poly-
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and monounsaturates may also be incorporated into tissues. The 
biohydrogenation process is facilitated by the rumen bacterial and protozoal 
population (Girard and Hawke, 1978). Rumen microorganisms such as 
Anaerovibrio lipolytics and Butyrivibrio fibrisolvens produce lipases, 
phopholipases and galactolipases. Acylglycerols, galactolipids and phopholipids 
are hydrolyzed to free FAs and galactose or glycerol. The galactose and glycerol 
are fermented in the rumen to volatile FAs with propionic acid being the final 
product. Unsaturated FAs are rapidly hydrolyzed by rumen microorganisms to 
more saturated end products. Generally the acids are converted to a mores 
stable trans form and double bonds are distributed in many positions along the 
acyl chain. 
The initial steps in the biohydrogenation of unsaturated FAs are carried 
out by the bacterium, B. fibrosolvens. An isomerase catalyzes the formation of a 
trans double bond only when the substrate contains a c9,c12 double bond 
system and has a free carboxyl group (Garton, 1977). c9,t11, c15 
octadecatrienoic acid is produced from its parent form of c9,c12,c15 
octadecatrienoic acid (linolenic acid) and c9,t11 octadecadienoic acid from 
c9,c12 octadecadienoic acid (LA). Enzymes of B. fibrosolvens continue to 
catalyze the conversion of the conjugated forms to the t11 octadecenoic form 
(vaccenic acid). Other rumen bacteria are responsible for the final conversion to 
stearic acid, the fully saturated form of C 18:0 (Kepler et al., 1966). Complete 
hydrogenation to a saturated form depends on conditions in the rumen. It is 
promoted by the presence of cell free ruminal fluid and feed particles, and 
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inhibited by large amounts of LA (Jenkins, 1993). Because the trans form is 
more difficult to hydrogenate, there is an accumulation of Transforms relative to 
cis forms. 
Lipids entering the small intestine are 70% saturated non-esterified FAs, 
which are of both dietary and microbial origin (Van Soest, 1994). The 
contribution of the microbial population to the lipids entering the small intestine 
are long chain FAs taken up by bacteria thus escaping biohydrogenation, and, 
FAs that are synthesized do novo (Van Soest, 1994). Some C16:1 and C18:1 
are produced by an anaerobic monounsaturated FA synthesis pathway or by 
action of an anaerobic desaturase on stearic acid (Jenkins, 1993). 
2.3. Glycerolipid Biosynthesis 
Glycerolipids are produced by esterification of FAs to a glycerol backbone 
through the action of the enzymes of the sn-glycerol-3-phosphate (G3P) 
pathway, monoacylglycerol (MAG) pathway, or by the action of diacylglycerol 
transacylase (DGTA) (Lehner and Kuksis, 1996). All of these pathways are 
associated with the microsomal fraction. 
The G3P pathway is associated with rough endoplasmic reticulum (ER) in 
liver and adipose tissue cells (Lehner and Kuksis, 1996). The stepwise 
esterification of FA moieties from acyl-CoA to the glycerol backbone produces 
lysophosphatidic acid (LPA) by the catalytic action of sn-glycerol-3-phosphate 
acyltransferase (GPAT) (EC 2.3.1.15) acting on G3P, or by the acylation of 
dihydroxyacetone phosphate which involves the catalytic action of the enzyme 
19 
dihydroxyacetone phosphate acyltransferase (EC 2.3.1.42) followed by a 
reduction reaction. Dihydroxyacetone phosphate is produced during glycolysis. 
Phosphatide acid (PA) is produced by the esterification of a FA to sn-2 of the 
LPA by lysophosphatidate acyltransferase (LPAAT) (EC 3.1.3.20). The PA is 
then dephosphorylated by the catalytic action of phosphatidate 
phosphohydrolase (PA phophatase) (EC 3.1.3.4) to produce an sn-1,2-
diacylglycerol (DAG). A third FA is attached to the sn-3 position of DAG by the 
catalytic action of diacylglycerol acyltransferase (DGAT) (EC 2.3.1.20) to form 
TAG. Alternatively the sn-1,2-DAG is used in other pathways for the synthesis of 
PLs such as phosphatidylcholine, phosphatidylethanolamine and 
phosphatidylserine. 
The MAG pathway is associated with the smooth ER in intestine cells 
(Lehner and Kuksis, 1996). The MAG pathway produces a DAG through the 
acylation of 2-MAGs, produced in the intestine by the action of pancreatic lipase, 
with the enzyme monoacylglycerol acyltransferase (MGAT) (EC 2.3.1.22). The 
DAG can then be utilized in the same way as those produced by the G3P 
pathway. 
Diacylglycerol transacylase (DGTA) catalyzes the synthesis of TAG from 
two DAG molecules in the absence of acyl-CoA by transferring an acyl chain 
form one DAG and leaving a 2-MAG as its other product. The enzyme was first 
purified from microvillus cells of rat intestine (Lehner and Kuksis, 1996). In non-
ruminant systems, the liver and intestine are involved in the synthesis and 
secretion of TAGs and adipose tissue is responsible for TAG storage and release 
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of FAs (Lehner and Kuksis, 1996). In the bovine, adipose tissue has a higher 
level of glycerolipid and FA biosynthesis than the liver (Wilson etai., 1992; Ingle 
ef al., 1972). Approximately 90% of lipid synthesis takes place in adipose tissue 
whereas the liver accounts for only 5% (Van Soest, 1994). The MAG pathway 
has not been studied in adipocytes of meat animals (Rule, 1995), but has been 
shown to be active in neonate sheep intestine and the ability to use this pathway 
is retained in adult sheep (Cunningham and Leat, 1969). The role of DGTA in 
animal TAG synthesis is in need of further investigation. Preliminary results have 
suggested that there might be some DGTA activity in bovine adipose and muscle 
tissues (R. J. Weselake, unpublished results). 
2.4. Effect of Dietary Lipids on FA Composition of Lipid Classes and 
Positional Distribution of FAs in Glycerolipids 
Dietary lipids that are broken down during ruminal lipolysis and 
biohydrogenation can be used by rumen bacteria as substrates for cellular 
growth. The generally saturated free FAs that are created in the rumen are 
absorbed and transported to other tissues as plasma lipoproteins. The chemical 
composition and the rate of secretion of lipoproteins are among the main factors 
that control lipid utilization by the tissues (Bauchart, 1993). Chylomicrons are 
synthesized by the ruminant intestine and transport dietary FAs to the tissues for 
fat storage or milk production. Increasing dietary fat stimulates secretion of 
chylomicrons or dietary polyunsaturated fat compared with saturated FAs. The 
presence of saturated FAs leads to secretion of LDL molecules by the intestinal 
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mucosal cells. 
Dietary fat is rapidly metabolized in the ruminant to a saturated form. 
Dietary manipulation of fat in order to result in an alteration of FA composition of 
tissues and milk is generally attempted through the use of what is known as 
protected fat. This is a dietary lipid supplement treated in such a way that fat is 
not metabolized in the rumen and passes to the small intestine as intact TAG. 
Pancreatic lipases then catalyze the degradation of the protected TAG to release 
FAs that have not been modified in the rumen. In this way polyunsaturated or 
other specific FAs can be absorbed. Dietary supplementation with different 
dietary oils has been shown to increase the CLA content of milk (Kelly et al., 
1998). CLA infused directly into the abomasum at a rate of 150g day'1 to by­
pass the rumen fermentation increased the milk fat CLA content by 10-fold while 
reducing the fat content of the milk by 50%. (Chouinard ef al., 1999) 
In non-ruminants, the FAs are not microbially altered before being 
incorporated into lipid biosynthesis pathyways. Studies involving chickens, pigs 
and humans have addressed the incorporation of dietary CLA into tissues. Egg 
yolk lipids analyzed after feeding hens CLA determined that CLA content of the 
egg yolk lipid was proportional to the level of CLA in the diet. More CLA was 
incorporated into the TAG fraction of the TL than the PL fraction (Du ef al., 1999), 
and concentrations of 18:1,18:2,18:3,20:4 and 22:6 were decreased 
(Chamruspollert etai, 1999). When pigs were fed CLA of known isomer 
composition the isomer distribution detected in backfat and omental fat TL, liver 
TAG, free FAs and cholesterol esters showed a similar pattern to that of the diet 
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(Kramer ef a/., 1998). 
Positional distribution refers to the organization of FAs esterified to the 
glycerol backbone of glycerolipids. The positions are numbered sn-1, sn-2, and 
sn-3 in Fisher projection (Figure 3) such that the FA on the middle carbon is on 
the left hand side and is considered to be in the plane of the page and the carbon 
is deignated sn-2. The top carbon is numbered sn-1 and the bottom carbon is 
numbered sn-3. The distribution of FAs on the glycerol backbone of animal fats is 
non-random and the positional distribution of FAs on the glycerol backbone of 
lipids is influenced by the length of the acyl chain and its degree of unsaturation. 
Shorter and more unsaturated FAs tend to occupy position 2 (Brockerhoff ef al, 
1966). Unusual FAs, along with foreign FAs, usually end up in the sn-3 position 
of the TAG molecules (Lehner and Kuksis, 1996) 
Positional distribution of FAs can be influenced by diet. Sheep fed 
protected sunflower seed oil that bypasses rumen biohydrogenation showed 
increased incorporation of 18:2 in the sn-1 and sn-2 postions of TAG (Hawke ef 
al, 1977; Mills era/, 1975). Protection from biohydrogenation results in a higher 
percentage of 18:2 available for incorporation into glycerolipids. A recent study 
by Smith ef a/. (1998) showed positional distribution changes in cattle fed various 
monounsaturated fatty acid (MUFA) and polyunsaturated fatty acid (PUFA) diets. 
Positional distribution of FAs on the glycerol backbone is thought to influence 
physical characteristics of the fat. Fats that are high in 18:0 in the 1 and 3 
positions are harder and are poorly absorbed which may explain why they are 
hypocholesterolemic. 
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Figure 3. Positional distribution and stereochemical numbering scheme on a 
Fisher projection model of a triacylglycerol molecule. 
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2.5. Hypothesis and Experimental Strategy 
The questions I wanted to answer in this thesis were whether dietary 
supplementation with CLA to pre-ruminant lambs, or LA rich oil (safflower oil) to 
weaned ruminating lambs, had any effect on lipid deposition in tissue, FA 
composition of tissue, and the positional distribution of FAs in TAG and PL. 
These studies may provide insight into possible mechanisms for incorporation of 
CLA into acylglycerols of animal tissues. 
Supplementation of ruminant diets with CLA, as conducted by Dugan et al. 
(1997) for non-ruminants is not possible because CLA would be rapidly 
hydrogenated in the rumen to stearic acid. In order to avoid this 
biohydrogenation, dietary supplementation with CLA has to occur when the 
animals are not ruminating. Pre-ruminant animals exhibit closure of the 
esophageal groove, a conditioned reflex, when consuming fluid meals up till 
weaning (Roy and Stobo, 1975) and are essentially similar to non-ruminants. In 
such a situation fluid meals pass directly from the mouth into the abomasun, 
avoiding the rumen and the possibility of biohydrogenation, thereby allowing the 
animal to absorb the dietary CLA unmodified in the intestine. 
For this study four four-week-old pre-ruminant lambs were supplemented 
with CLA in milk replacer, and four seven-week-old weaned ruminating lambs 
were supplemented with LA rich oil in pelleted feed. Five, lambs were carried 
through both feeding phases as controls with no dietary supplement. At 
slaughter tissue samples were taken for analysis. Data obtained from feeding 
pre-ruminant animals with CLA, and those receiving LA rich oil supplemented 
feed as weaned animals was compared with control animals receiving 
supplements. 
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The work described in the following paper was presented by my co-
supervisor, Dr. Z. Mir, at the Canadian Society for Animal Science annual 
meeting in Montreal in 1998. I was unable to prepare and present the material in 
its entirety due to timing and funding constraints. I did, however, run the feeding 
trial and tissue sampling aspects of the experiment and I was also responsible for 
establishing the lipid extraction, methylation, gas chromatography and statistical 
analysis protocols. Mr. M. L. Rushfeldt assisted in the analysis of the TL 
extracted from the sampled tissues by carrying out these established protocols 
while my focus changed to establish positional distribution analysis protocols 
used in the further characterization of the PL and TAG fractions of the TL from 
samples procured from animals in the trial. The following manuscript on this 
work has been published in Small Ruminant Research as. 
Effect of dietary supplementation with either conjugated linoleic acid (CLA) 
or linoliec acid rich oil on the CLA content of lamb tissues. Z. Mir, M. L. 
Rushfeldt, P. S. Mir, L. J. Paterson and R. J. Weselake. Small Ruminant 
Research, Volume 36, Issue 1, April 2000, pages 25-31. 
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3. Effect of Dietary Supplementation with either Conjugated 
Linoleic Acid (CLA) or Linoleic Acid Rich Oil on the CLA Content 
of Lamb Tissues. 
3.1. Abstract 
Conjugated linoleic acid (CLA) is produced in the rumen by isomerization 
of linoleic acid (LA) and has been shown to be a potent anticarcinogen in animal 
model studies. The objective of this study was to compare the relative increase in 
the CLA content of lamb tissues by dietary CLA supplementation (0.33 g/d for 21 
days prioir to weaning) to milk-replacer of pre-ruminant lambs or by feeding LA 
rich oil (Safflower oil, 6% DM- SAFF) to weaned ruminating lambs with that of 
lambs receiving unsupplemented milk replacer and pelleted feed. Thirteen lambs 
were randomized to three dietary treatments (CLA - 4, SAFF - 4 and Control - 5) 
and fed the pelleted diet for 80 days after weaning. Lambs were slaughtered at 
an average weight of 45 kg and tissue samples were procured from pars costalis 
diaphragmatis, leg, rib, subcutaneous adipose and liver for determination of fat 
and CLA content and fatty acid composition. Dietary supplementation with 
safflower oil increased fat content of subcutaneous adipose tissue only, but the 
CLA content of all the tissues was increased (P < 0.05) by more than 200%. 
Dietary safflower oil increased (P < 0.05) C18:2 in all tissues and C16:0 in the 
diaphragm and decreased (P < 0.05) C18:1 and C18.3 content in all tissues. 
Supplementation of the diet with preformed CLA prior to weaning decreased (P 
< 0.05) fat content of the adipose tissue with decreases occurring in C18:0 
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relative to animals receiving the unsupplemented diet However, tissue CLA 
content was not affected by provision of dietary CLA to preruminant lambs. 
Results indicated that supplementation of lamb feedlot diets with a source of LA 
was a successful method of increasing CLA content of tissues. 
3.2. Introduction 
Conjugated linoleic acids (CLA) are produced by bioconversion of LA by 
the bacterium Butyrivibrio fibrosolvens in the rumen (Kepler et al. 1966) and are 
intermediary metabolites in the production of stearic acid. Currently, CLA are 
defined as a combination of several positional and geometric isomers with double 
bonds predominantly at the 9 and 11,10 and 12 or 11 and 13 carbon atoms, with 
various combinations of cis and trans configuration at each double bond. 
Although CLA represent a relatively minor component of the total fatty acid 
composition of foods, CLA exhibit chemoprotective properties against 
carcinogens when consumed at very low levels (<1% of the diet; Ip, 1997 or 3.5 
g/d Ha et al., 1989). These values were extrapolated from rat studies. Recently 
Knekt et al.(1996)reported reductions in incidence of breast cancer in women 
consuming 55mg CLA /d from milk. In general, meat and dairy products from 
ruminants contain more CLA than products from nonruminants (Fogerty et al., 
1988; Jiang et al., 1996). The concentration of CLA in beef ranges from 1.7 to 
8.5 mg CLA/g fat and is dependent on the nature of feed fed to the animals 
(Shantha et al., 1994; Mir et al., 1999). Canoia oil or full-fat rapeseed 
supplementation of diets fed to goats or dairy cows, respectively, increased CLA 
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content in milk, ranged from 10.35 (control) to 32.05 and 3.91 (unsupplemented) 
to 7.89 mg per g of lipid (Mir et al., 2000; Stanton et al., 1997). To our 
knowledge, effects of dietary oil supplementation on CLA content in ruminant 
muscle, adipose and liver tissues have not been reported previously. 
Supplementation of ruminant diets with CLA, as conducted by Dugan et al. 
(1997) for nonruminants, is not possible because CLA would be rapidly 
hydrogenated in the rumen to stearic acid. In order to avoid this 
biohydrogenation, dietary supplementation with CLA has to occur when the 
animals are not ruminating. Preruminant animals exhibit closure of the 
esophageal groove, a conditioned reflex, when consuming fluid meals up till 
weaning (Roy and Stobo, 1975).and are essentially similar to non-ruminants In 
such a situation fluid meals pass directly from the mouth into the abomasum, 
avoiding the rumen and the possibility of biohydrogenation, thereby allowing the 
animal to absorb the dietary CLA unmodified in the intestine. 
The objective of this study was to compare the relative increase in the 
CLA content of lamb tissues by dietary CLA supplementation to milk-replacer of 
pre-ruminant lambs or by feeding LA rich oil (safflower oil) to weaned ruminating 
lambs with that of lambs receiving unsupplemented milk replacer and pelleted 
feed. 
3.3. Materials and Methods 
3.3.1. Lambs and Diets 
Thirteen, four week old crossbred lambs (avg. wt. 12.5 ±3.43 kg) were 
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removed from ewes and placed in two pens with free access to milk replacer 
from an artificial ewe feeding apparatus for 21 days. The lambs had free access 
to a pelleted creep feed containing barley grain, alfalfa, and soybean meal. Each 
of the lambs in the control treatment (5 lambs) and those designated to receive 
the safflower oil (SAFF; 4 lambs) upon weaning were given 50 ml_ of milk 
replacer containing 5 ml_ of olive oil (carrier), daily by bottle. Lambs in the CLA 
treatment (4 lambs) received 50 mL of milk replacer containing 0.33 g CLA 
(Pharmanutrients, Lake Bluff IL, USA) dissolved in 5 mL of olive oil daily. 
After 21 days, the lambs (avg. wt. 18.9 +.3.38 kg) were weaned off the 
artificial ewe and, housed in individual pens and provided with a pelleted diet ad 
libitum. The lambs in the control treatment and those that received CLA 
supplemented milk-replacer, were provided with the pelleted diet, while the lambs 
in the SAFF treatment received the pelleted diet supplemented with 6% safflower 
oil on a dry matter basis. Safflower oil purchased from a commercial source was 
guaranteed to contain 78% linoleic acid and Chin et al (1992) reported that 
commercial safflower oil contains 0.7 mg CLA/g fat. The ingredient composition 
of the pelleted diet was: barley, 56.2%; dehydrated alfalfa, 29.5%; soybean meal, 
9.0%; molasses, 2.0%; sheep mineral, 1.05%; maxi-pel, 1.0%; CaP0 4 , 0.5%; 
NH4CI, 0.5%; dicalcium phosphate, 0.2%; vitamin A (10 million IU kg'1), vitamin D 
(1 million IU kg'1), and vitamin E (100 000 IU kg'1), 0.0333%; and deccox premix, 
0.0181%. The crude protein of this diet was 16.6%. Lambs were fed for 80+1.8 
days on this diet. The average weight at slaughter was 45.9 +_2.9kg. 
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3.3.2. Tissue Samples 
At the time of slaughter, samples of the diaphragm, liver and adipose 
tissue of each animal were obtained. A leg roast and double chop from the 12 t h 
and 13 t h ribs were later sampled from each animal at the time of cutting. All 
samples were obtained from the same half of the carcass. All of the samples 
were stored at -40°C until ready for analysis. Samples were thawed at 4°C and 
subsamples were taken for dry matter analysis and ground with a hand grinder 
until they were completely blended, and then were refrozen at -20°C. 
3.3.3. Lioid Extraction and Fattv Acid Analysis 
The Folch method (Folch et al 1957) was used for lipid extraction. 
Approximately 500 mg of frozen meat samples were weighed into a test tube, 
and 1 mL of chloroform/methanol (2:1 v/v) mixture was added. The sample was 
homogenized in a ground glass tissue grinder, for 30 sec at 4°C. The 
homogenizer was rinsed two times in 2 mL of the same chloroform/methanol 
mixture (total 4 mL), and the rinse fluid was combined with the homogenate. The 
tube was flushed with nitrogen and spun at 3000 rpm (1250 x g) for 30 min at 
room temperature. The supernatant was quantitatively transferred to a clean test 
tube and 400 FL of 0.29% NaCI solution were added. The tube was flushed with 
nitrogen and placed on a test tube rocker for 10 min, after which it was 
centrifuged at 3000 rpm (1250 x g) for 30 min at room temperature. The 
chloroform layer was transferred to pre-weighed vials equipped with teflon-lined 
caps, flushed with nitrogen and stored at -20°C until required for methylation. 
The chloroform was evaporated under nitrogen while the vials were placed 
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in a 40°C water bath, and the total amount of lipid extracted was determined 
gravimetrically. A known amount of extracted lipid was derivatized using 
tetramethylguanidine (TMG) and methanol, as described by Shantha et al. 
(1993), and the fatty acids in the samples were separated by gas 
chromatography as described by Mir et al. (1998b). 
3.3.4. Statistical Analysis 
Data were analyzed as a completely randomized design experiment with 
uneven replication using the General Linear Model of SAS (Statistical Analysis 
Systems Institute Inc., 1992); orthogonal contrasts: Control vs. CLA 
supplementation prior to weaning and Control vs. SAFF supplementation after 
weaning were used to compare differences in treatment means. 
3.4. Results 
3.4.1. Growth Performance 
The average daily growth rate of lambs during pre-weaning was 305+66 g 
per day and difference due to treatment was not observed. The rate of gain of 
lambs, post-weaning, in the control, CLA, SAFF treatment groups was 382, 301 
and 349 + 21 g per day and dry matter intake was 1.43,1.24 and 1.21 + 0.06 kg 
per day, respectively. The rate of gain of lambs in the CLA treatment group was 
less than that of the lambs in the control group while the dry matter intake of 
lambs in both the CLA and SAFF treatment groups was lower than that of lambs 
in the control group. The feed conversion efficiency tended to be better for lambs 
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in the SAFF treatment (3.5) relative to those in the CLA treatment (4.1) and 
neither treatment was different from the control 
3.4.2. Total Lipid Content 
Quantities of TL extracted from the various tissues are shown in Table 1. 
No significant differences in TL extracted from samples of the diaphragm, leg, rib 
and liver obtained from lambs on the three dietary treatments were observed. 
However, the quantity of lipid extracted from the subcutaneous fat of the lambs 
provided CLA prior to weaning was considerably lower (P < 0.05) than the 
control, whereas that from lambs fed the SAFF supplemented diet, post-weaning, 
was significantly higher, compared with that of lambs fed the unsupplemented 
diet. The liver of lambs fed CLA contained significantly lower (P < 0.05) amounts 
of lipids when compared with that of lambs in the control treatment. 
3.4.3. CLA Concentration 
Significant differences were observed when the CLA concentration in the 
various tissues was compared across dietary treatment (Table 2). 
Supplementation of lamb diets with SAFF resulted in increases (P < 0.05) in the 
amount of CLA in the tissues when compared with that of animals fed the 
unsupplemented control diet. The CLA content was not affected in any of the 
tissues examined from lambs fed CLA-supplemented milk replacer prior to 
weaning. 
3.4.4. Fatty Acid Composition 
The tissue compositions of other non-volatile major straight chain fatty 
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acids are presented for the diaphragm, leg and rib muscle, and adipose and liver 
tissue in Table 3. The C16:0 content was not significantly affected by CLA 
supplementation in any of the tissues examined. However, SAFF 
supplementation significantly increased C16:0 content in diaphragm muscle 
when compared with lambs fed the unsupplemented diet. The C18:0 content of 
adipose tissue was significantly reduced with CLA supplementation but other 
tissues were not affected. Dietary supplementation with CLA pre-weaning had no 
effect on C18:1 content in any of the tissues studied. However with SAFF 
supplementation, the C18:1 content was significantly reduced in all the tissues. 
The C18:2 content was significantly reduced with CLA supplementation in 
diaphragm muscle and adipose tissue, but not in leg and rib muscle and liver. 
Supplementation with SAFF increased (P < 0.05) C18:2 and decreased C18:3 
content in all the tissues examined. The C18:3 content of muscle tissue was not 
affected by CLA supplementation, but there was a significant decrease in the 
level of this fatty acid in adipose tissue and a significant increase in the liver 
tissue. 
3.5. Discussion 
The growth rate of lambs in this study was within the range for lambs that 
have moderate to high growth potential as defined by NRC (1985). The absence 
of differences in feed conversion efficiency was due to lower intakes in lambs in 
the CLA and SAFF treatment groups relative to that observed for control lambs 
Conjugated linoleic acid concentration of tissues is higher in ruminants 
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compared to nonruminants. In the first feeding approach, CLA was fed to 
preweaned lambs for direct deposition into the tissues. Secondly, the diet was 
supplemented with LA rich SAFF to enhance ruminal bacterial activity for the 
conversion of linoleic acid to CLA isomers. 
Direct feeding of CLA to pre-weaned lambs did not increase the CLA 
content in any of the examined tissues. The CLA was probably metabolized for 
energy by the growing lambs. However there was a highly significant decrease in 
the amount of lipid extracted from the subcutaneous adipose tissue when 
compared with animals receiving the control diet. Similar highly significant 
reductions in body fat has been observed in pigs, mice, rats and chickens fed 
diets containing CLA (Dugan et al., 1997; Park et al., 1997; Pariza et al., 1996). 
The decrease in fat content in subcutaneous adipose tissue may be related to 
differences in induction of differentiation of fibroblasts to adipocytes. LA is 
considered to be a strong inducer for differentiation of fibroblasts to adipocytes 
via activation of peroxisome proliferation activator receptor -gamma (Lazar, 
1998). The change in configuration of C18:2 may disable the system to recruit 
fibroblasts to differentiate into adipocytes and may be the reason for the lower fat 
content in mature adipose tissue in lambs fed CLA prior to weaning. However, in 
weaned lambs, supplemented with SAFF, the availability of CLA from rumen did 
not decrease fat content of adipose tissue, suggesting that CLA is not effective in 
restricting lipid accumulation once fibroblast differentiation into adipocytes has 
occurred. 
The decrease in the liver lipid accumulation with dietary CLA in lambs was 
opposite to the observation in rodent liver (Belury and Kempa-Steczko, 1997), 
which suggested that there may be a species difference. Nevertheless, these 
data support the suggestion by Belury and Kempa-Steczko (1997) that dietary 
CLA may have a role in lipid transport and metabolism. 
A consistent significant increase in CLA content in all the tissues was 
observed with SAFF supplementation. These results indicated that provision of 
the precursor to CLA, LA, in the diets of ruminants is required to increase the 
CLA content of the body tissues. It is apparent that CLA produced in situ by 
isomerization of LA during biohydrogenation in the rumen is an effective method 
of increasing the CLA content of tissues. Similar increases in CLA content in 
milk have been observed in recent studies (Kelly et al., 1998; Mir et al., 2000). 
To our knowledge, effects of oil supplementation to the diet on CLA content in 
ruminant muscle, adipose and liver tissues have not been reported previously. 
The concentration of CLA in muscle samples from control lambs ranged from 
0.64 to 3.13 mg CLA/g lipid and were within the range of values reported for 
various muscle tissue from lambs (Hansen and Czochanska, 1976; Fogerty et 
al., 1988). However, values for muscle from control lambs in the present study 
were lower than the value of 5.6 mg CLA/g lipid in lambs (Chin et al., 1992). In 
all these studies meat from lambs was purchased from retail stores and thus it 
was not possible to determine the effect of feeding regimen on CLA content. In 
the present study, SAFF oil supplementation increased the CLA content in rib 
muscle to 8.4 mg CLA/g lipid, which was 1.7-fold higher than in the rib muscle 
from control animals. This value was greater than the CLA content (7.4 mg 
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CLA/g lipid) in beef round muscle from grass fed cattle (Shanta et al., 1997). In 
this study the average content of CLA for leg and rib muscle for lambs in control 
and SAFF treatment was 76.6 and 178.6 mg/100 g tissue, respectively. At a 
consumption rate of 250 g/d of lamb per day, the intake of CLA would be 
approximately 192 mg and 446 mg from meat from lambs from the two 
treatments respectively, and substantially greater than the 55 mg/d of CLA that 
resulted in reducing incidence of breast cancer in women (Knekt et al., 1996), 
but considerably less than the 3.5 g/d of CLA determined by extrapolation from 
rat studies, to promote of human health benefits. (Ha et al., 1989) 
Content of CLA in liver and adipose tissue from lambs fed SAFF oil were 
not as high as the values of 12.6 and 16.9 mg CLA/g lipid reported by Banni et a l . 
(1996) in liver and adipose, respectively. This was perhaps due to the 
differences in the age of the animals and dietary conditions. In the present study, 
the average age was about 3.5 months and the lambs received milk replacer and 
high concentrate diets, while the suckling lambs in the study by Banni et al 
(1996) were one month of age and were nursed by ewes grazing on grass 
pasture. 
Although the primary objective of this investigation was to determine the 
effect of dietary supplementation with CLA (pre-weaning) or SAFF (post-
weaning) on CLA content of tissues, the composition of other non-volatile fatty 
acids such as C16:0 and C18 straight chain fatty acids were also affected by 
dietary treatments. The effect of CLA supplementation on fatty acid composition 
in lamb tissue has not been previously reported, but present data indicate that 
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there was substantial variation among tissues. In rats, C18:0 concentration in 
liver has been reduced with a CLA-supplemented diet (Belury and Kempa-
Steczko, 1997),whereas in the present study, the C18:3 concentration in lamb 
liver was significantly increased. The increase in C18:2 content of all the tissues 
with SAFF supplementation of the diet was consistent with observations in other 
studies cited by Rule et al., (1995), that have utilized vegetable oil in lamb diets. 
The decreases in C18.1 and C18:3 content in lamb tissues in the present study, 
however, have not been reported previously. From a human health perspective, 
an increase in CLA content is beneficial (Ip, 1997) but a decrease in C18:1 in 
tissue is not desirable. 
In conclusion, supplementation of lamb feedlot diet with a rich source of 
LA resulted in a significant increase in the CLA content of various tissues. Direct 
CLA supplementation of pre-ruminant lambs did not influence CLA content in the 
tissues. In this case, CLA may have modulated fatty acid metabolism as has 
been observed in non-ruminants. 
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Table 1 
safflower oil (SAFF) on lipid concentration (%) in various tissues. 
Diet treatment 
Tissue Control CLA SAFF SEM CLA SAFF 
Muscle 
Diaphragm 26.9 31.5 25.0 1.88 NS NS 
Leg 12.8 13.9 14.8 1.18 NS NS 
Rib 49.8 51.0 41.1 3.57 NS 0.09 
Adipose 71.7 58.7 82.6 3.00 * * 
Liver 13.6 11.1 13.5 0.77 * NS 
SEM, Standard error of the mean. 
NS, Not significant. 
*, significant P>0.05. 
The effect of dietary supplementation with conjugated linoleic acid (CLA) or 
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Table 2 
safflower oil (SAFF) on CLA concentration in various tissues. 
Diet treatment Contrasts: Control vs 
Tissue Control CLA SAFF SEM CLA SAFF 
Muscle 
Diaphragm 0.84 0.83 2.60 .0174 NS •** 
Leg 1.78 1.50 4.41 0.432 NS *** 
Rib 3.13 3.40 8.41 0.473 NS *** 
Adipose 2.77 2.60 7.33 0.232 NS *** 
Liver 1.72 1.59 3.53 0.349 NS *** 
SEM, Standard error of the mean. 
NS, Not significant. 
***, signifiant P>0.001 
The effect of dietary supplementation with conjugated linoleic acid (CLA) or 
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Table 3 
The effect of dietary supplementation with conjugated linoleic acid (CLA) or 
safflower oil (SAFF) on fatty acid concentration (weight %) in various 
tissues. 
Diet treatment Contrasts: Control vs 
Fatty acid Control CLA SAFF SEM CLA SAFF 
Diaphragm 
16:0 22.7 24.9 25.1 0.49 NS * 
18:0 19.1 18.1 19.3 0.52 NS NS 
18:1 47.7 49.1 41.4 1.12 NS * * * 
18:2 9.4 6.6 13.4 0.65 **» * * * 
18:3 1.0 1.1 0.4 0.09 NS * » * 
Leg 
16:0 27.5 29.3 29.7 0.45 NS NS 
18:0 14.7 12.5 16.9 0.47 NS NS 
18:1 47.9 482 39.7 0.62 NS * * * 
18:2 8.6 8.6 12.4 0.49 NS * * * 
18:3 1.1 1.3 1.7 0.06 NS •** 
Rib 
16:0 30.0 32.0 32.1 0.49 NS NS 
18:0 17.4 14.9 20.0 0.66 NS NS 
18:1 45.5 45.9 38.0 0.75 NS *#* 
18:2 5.7 5.4 8.5 0.33 NS ««* 
18:3 1.3 1.5 0.7 0.12 NS •** 
Adipose 
16:0 282 30.9 32.4 0.64 NS NS 
18:0 12.1 8.2 14.3 0.81 * * * NS 
18:1 52.5 56.9 432 1.35 NS * * * 
18:2 5.8 3.3 8.4 0.33 * * * * * * 
18:3 12 0.5 0.7 0.10 * * * * * * 
Liver 
16:0 23.4 23.4 21.6 0.55 NS * 
18:0 33.3 34.6 32.8 0.74 NS NS 
18:1 25.0 222 213 126 NS * 
182 162 17.2 22.7 0.98 NS * * * 
18:3 1.9 2.5 0.8 0.17 * 
SEM, Standard error of the mean. 
NS, Not significant 
*, significant P>0.05. 
***, significant P>0.001 
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4 . Incorporation of Conjugated Linoleic Acid (CLA) into 
Glycerolipids of Lamb Tissues. 
4.1. Abstract 
The meat of ruminants contains conjugated linoleic acids (CLA) that have 
been shown to have nutraceutical value in preventing cancer and reducing the 
risk of heart disease. CLA are produced in the rumen by isomerization of linoleic 
acid. The objective of this study was to examine the level of CLA (composed 
mainly of the c/s-9, frans-11-octadecadienoate isomer) in triacylglycerols (TAGs) 
of lamb tissue and the distribution of CLA on the TAG molecule as influenced by 
dietary regime. The CLA content of phospholipid (PL) from these tissues was 
also examined along with the positional distribution of CLA in PL of liver tissue. 
Thirteen lambs were randomized to three dietary treatments: 
1) control diet (no supplement); 2) CLA supplementation (0.33 g d"1 for 21 d prior 
to weaning) to milk-replacer of pre-ruminant lambs; and 3) feeding linoleic acid-
rich oil (Safflower oil, 6% DM- safflower) to weaned ruminating lambs. Lambs 
were slaughtered at an average weight of 45 kg and tissue samples were 
procured from diaphragm, rib and subcutaneous (SC) fat tissue for determination 
fatty acid (FA) composition of TAG and PL, and positional distribution of FAs on 
TAG. Liver tissue was procured for determination of the FA composition of PL 
and positional distribution of FAs on PL. Safflower oil supplementation in the 
diet resulted in an increase in CLA content of the TAG from diaphragm, rib and 
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SC fat by about 2.5- to 3-fold (P < 0.05). CLA was localized to the sn-1/3 
positions of TAG suggesting that acyltransferase in these tissues had a lower 
prference for CLA moieties compared to other fatty acyl moieties. Animals that 
received pre-formed CLA, however, had increased proportions of CLA at the sn-2 
position of TAG from SC fat. Safflower supplementation in the diet had no effect 
on the CLA content of PL from diaphragm, rib and SC fat tissue suggesting that 
CLA was preferentially incorporated into the TAG of these tissues. Positional 
distribution studies with PL from liver tissue, however, indicated that CLA was 
exclusively localized to the sn-2 position of the glycerol backbone. 
4.2. Introduction 
Conjugated linoleic acids (CLA) are produced in ruminant animals by the 
bacterium Butyrivibrio fibrisolvens (Kepler et al., 1966). CLA isomers are 
intermediary metabolites in the bioconversion of dietary linoleic acid (18:2) to 
stearic acid (18:0) by Butyrivibrio fibrisolvens. Currently, CLA are defined as a 
combination of several positional and geometric isomers of 18:2 with double 
bonds predominantly at the 9 and 11,10 and 12, or 11 and 13 carbon atoms, 
with various combinations of cis and trans configuration at each double bond. 
Although CLA represent a relatively minor component of the total FA composition 
of foods, CLA exhibit chemoprotective properties against carcinogens when 
consumed at very low levels (<1% of the diet or 3.5 g d'1) (Ip, 1997; Ha ef al., 
1989). Knekt ef al. (1996) reported reductions in incidence of breast cancer in 
women consuming 55mg CLA d'1 from milk. 
In general, meat and dairy products from ruminants have been shown to 
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contain more CLA than products from nonruminants (Fogerty etai., 1988; Jiang 
etai., 1996). The concentration of CLA in beef has been shown to range from 
1.7 to 8.5 mg CLA g'1 fat and is dependent on the nature of the feed (Shantha ef 
al., 1994; Mir etai., 1999). Canola oil or full-fat rapeseed supplementation of 
diets fed to goats or dairy cows, respectively, increased CLA content in milk (Mir 
ef al., 2000; Stanton eta/., 1997). In a study using rats, a diet that included 5% 
free 18:2 significantly increased the CLA concentration of both the neutral lipid 
(NL) and phospholipid (PL) fractions of liver tissue samples (Chin eta/., 1994a). 
As well, inclusion of pre-formed CLA in rat diets resulted in a 6-fold increased in 
the CLA content of the PL fraction compared to the controls (Ip ef al., 1991). In 
a more recent study using mice, a dose dependent increase in CLA concent was 
observed in epidermal NL and PL as CLA in the diet was increased from 0% to 
1.5% (Kavanough ef al., 1999). CLA and conjugated diene intermediates have 
also been found in the PL fraction from lamb liver (Banni etai., 1996). 
In section 3 of this thesis, it was demonstrated that safflower 
supplementation in the diet enhanced the CLA content of various lamb tissues 
through provision of thel 8:2 precursor of CLA (Mir et al., 2000). In the current 
study, lipid samples were isolated from rib, diaphragm, SC fat and liver of lambs 
fed either CLA as a free acid pre-weaning (pre-ruminating), or a high 18:2 diet 
post-weaning (ruminating) to investigate effects on the CLA content of TAG and 
PL. Analysis of the positional distribution of CLA in TAG from diaphragm, rib and 
SC fat was conducted in order to gain some insight into the mechanism of CLA 
incorporation into glycerolipids. PL from liver tissue was included in the 
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positional distribution studies for comparative purposes. 
4.3. Materials and Methods 
4.3.1. Lambs and Diets 
Thirteen four week old crossbred (Suffolk x Dorset) lambs (avg. wt. 12.5 ± 
3.43 kg) were removed from ewes and placed in two pens with free access to 
milk-replacer from an artificial ewe feeding apparatus for 21 d. The lambs had 
free access to a pelleted creep feed containing barley grain, alfalfa and soybean 
meal. Each of the lambs in the control treatment (5 lambs) and those designated 
to receive the 6% safflower oil diet (4 lambs) upon weaning were given 50 mL of 
milk replacer containing 5 mL olive oil (carrier), daily by bottle. Lambs in the CLA 
treatment group (4 lambs) received 50 mL milk-replacer containing 0.33 g CLA 
(Pharmanutrients, Lake Bluff, IL, USA) dissolved in 5 mL of olive oil daily. After 
21d, the lambs (avg. wt. 18.9 ± 3.38 kg) were weaned off the artificial ewe, and 
housed in individual pens and provided with a pelleted diet ad libitum. The lambs 
on the control and those that received CLA supplemented milk-replacer (pre-
weaning) were supplied with the pelleted diet, while the lambs on safflower oil 
received the pelleted diet supplemented with 6% safflower oil on a dry matter 
basis. Safflower oil purchased from a commercial source was guaranteed to 
contain 78% 18:2. Chin et al. (1992) has reported that commercial safflower oil 
contains 0.7 mg CLA g'1 lipid. The ingredient composition of the pelleted diet 
was: barley, 56.2%; dehydrated alfalfa, 29.5%; soybean meal, 9.0%; molasses, 
2.0%; sheep mineral, 1.05%; maxl-pel, 1.0%; CaP0 4 ,0.5%; NH4CI, 0.5%; 
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dicalcium phosphate, 0.2%; vitamin A (10 million IU kg'1), vitamin D (1 million IU 
kg*1), and vitamin E (100 000 IU kg'1), 0.0333%; and deccox premix, 0.0181%. 
The crude protein of this diet was 16.6%. Lambs were fed for 80+1.8 d on this 
diet. The average weight at slaughter was 45.9 ± 2.9 kg. 
4.3.2. Tissue Samples 
At the time of slaughter, samples were procured from diaphragm, SC fat 
and liver. A double chop from the 12 t h and 13 t h ribs was sampled from each 
animal at the time of cutting. All tissue samples were obtained from the same 
half of the carcass. Tissue samples were stored in Whirl-Pak bags with as little 
air as possible, kept on ice for approximately 30 minutes and then frozen in liquid 
N 2 . Tissues were stored at -20°C until use. Samples were thawed at 4°C and 
subsamples were taken and ground with a hand grinder until completely blended, 
and then refrozen and stored at -20°C. 
4.3.3. Lipid Extraction 
Lipids were extracted using CHCI3:MeOH (2:1, v/v) (Folch etai, 1957). 
Stored tissue was thawed at 4°C and 500 mg of tissue were weighed into a test 
tube and homogenized in 5 mL of CHCI3:MeOH (2:1, v/v), using a Kinematica 
homogenizer model PT-10-35 (Brinkman Inst., Rexdale, ON, Canada) at speed 
setting 6 for 30 seconds. The probe was rinsed with 5 mL CHCI3:MeOH (2:1, v/v) 
and the rinse and homogenate were combined and centrifuged at 3000 rpm 
(1250 x g) for 30 min. The supernatant was washed two times with 2 mL 0.29% 
NaCI (w/v), and the final organic phase was passed through a small column of 
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anhydrous Na2S04to remove water from the sample. The lipid extract was then 
evaporated to dryness under N 2 gas with gentle heating (37°C to 40°C). The 
total lipid (TL) was dissolved in CHCI3to a final concentration of 150 mg ml'1 and 
stored at -20°C under gaseous N 2. 
4.3.4. Lipid Class Separation 
Using the method of Juaneda and Rocquelin (1985) modified by Chin et al 
(1994a), 30 - 60 mg of TL in 500 u.L - 1 mL CHCI3 was fractionated into NL and 
PL fractions. The TL was loaded onto a silica cartridge. (Sep-Pak Classic, 
Waters Limited, Mississauga, ON) and the fraction eluted in three steps. The NL 
fraction was eluted with 20 mL CHCI3 injected by syringe at a flow rate of 
approximately 25mL min'1. Monoacylglycerol (MAG) was eluted with 10 mL 
CHCI3:MeOH (98:2, v/v) at a flow rate of approximately 20 mL min'1. The PL 
fraction was eluted with 30 mL methanol at a flow rate of 25 mL min'1 The PL and 
NL fractions were evaporated to dryness under N 2 and dissolved in CHCI3 to a 
final concentration 10mg mL'1 then stored under N 2 gas at -20°C. 
4.3.5. TAG Isolation 
Two hundred microliters of 150 mg TL ml*1 (30 mg TL total) were applied 
to a pre-run EM Science HPTLC- Fertigplatten Kieselgel 60 silica gel plate (10 x 
20 cm x 0.25 mm thick) (VWR, Canlab, Mississauga, ON). Fifty microliters of 10 
mg triolein mL'1 were applied as a reference standard (Sigma Aldrich Canada, 
Oakville, ON, Canada). Lipids were separated by one ascension of 
hexane:ether:acetic acid (80:20:1 v/v/v) as a solvent system (Pomeroy et al., 
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1991). The isolated TAG was dissolved in CHCI3 to a concentration of 10mg mL'1 
and stored under N 2 gas at -20°C. 
4.3.6. Digestion of TAG Using Pancreatic Lipase 
Using the method of My her and Kuksis (1979), pancreatic lipase was used 
to generate sn-2 monoacylglycerol (2-MAG) from TAG. Two milligrams TAG 
were evaporated to dryness under N2gas. The dried TAG was suspended in 500 
uL of pancreatic lipase buffer (1M Tris-HCI, pH 8.0,10% (w/v) Gum Arabic, 0.23 
MCaCI2 (w/v)) by sonication. Five hundred microliters of pancreatic lipase buffer 
containing 8 mg mL'1 pancreatic lipase were added to the TAG suspension, the 
mixture was vortexed briefly and incubated at 37°C for 1h in a shaking water 
bath. The reaction was stopped with 500 u.L of 0.1 N acetic acid and the lipid was 
extracted three times with 2 mL diethyl ether. Ether extract was passed over 
anhydrous Na 2 S0 4 , combined and then evaporated to dryness under N2gas. 
The extracted lipid was redissolved in 100-200 u.L CHCI3 and applied to boric 
acid TLC plates. Fifty microliters of a 10 mg mL'1 solution of monolein (Sigma 
Aldrich Canada, Oakville, ON, Canada) were applied as a reference standard. 
Lipids were separated by one ascension of CHCI3:acetone (88:12, v/v) as a 
solvent system (Myher ef al, 1996). 
4.3.7. Digestion of Liver PL Using Phosoholinase A? 
Two milligrams of liver PL were sonicated for ten minutes in 1 mL of 
borate buffer (diethyl ether: borate pH 8.9 (1:1 v/v)). Twenty five units of 
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phospholipase A 2 from Apis mellifera venom (Sigma Aldrich Canada, Oakville, 
ON, Canada) were added and the mixture incubated at 37°C for 2h with gentle 
shaking. The reaction was stopped with 500 uL of 0.1 N acetic acid and the ether 
evaporated under N2gas. The lipid was extracted from the reaction three times 
with 2 mL of CHCI3:MeOH (2:1 v/v). The extracts were passed over anhydrous 
Na 2 S0 4 and combined. After evaporating to dryness under N 2 , the lipid was 
resuspended in 100 - 200 ul CHCI3 and applied to boric acid TLC plates. Fifty 
microliters of 10 mg mL'1 solution of lysophosphatidic acid (LPA) (Sigma Aldrich 
Canada, Oakville, Ont., Canada) was applied as reference standard. Lipids were 
separated by one ascension of CHCl3/EtOH/H20/triethylamine (35:30:6:35, v/v) 
as a solvent system. 
4.3.8. Elution of TAG and MAG from Silica Gel 
TAG and MAG standards were visualized with iodine vapor. The silica 
containing the fraction of interest was removed from the TLC plate with a glass 
microscope slide onto glasine paper and transferred to a methanol washed test 
tube. Lipids were eluted from silica by extracting twice with 5 mL of CHCI3 and 
once with 2 mL of the solvent. The slurry was shaken vigorously and centrifuged 
at 400 x g for 5 minutes. Each eluted fraction was passed over anhydrous 
Na 2 S0 4 . The dehydrated fractions were combined and was stored at -20°C 
under N 2gas. 
4.3.9. Elution of LPA from Silica Gel 
The LPA standard was localized by spraying the plate with a solution of 5 
50 
mg primulin mL'1 in acetoneiwater (4:1, v/v) and visualizing under ultraviolet light. 
The silica containing the fraction of interest was removed from the TLC plate with 
a glass scraper onto glasine paper and transferred to a test tube. LPA was 
eluted from the silica by extracting sequentially with 4 mL portions of developing 
solvent and CHCI3:MeOH:H20 (5:5:1, v/v). The slurry was shaken vigorously and 
centrifuged at 400 x g for 5 min. The extracts were combined and partitioned with 
4mL H 2 0. The organic phase was passed over anhydrous Na 2 S0 4 and stored at 
-20°C under gaseous N 2. 
4.3.10. Preparation of Boric Acid TLC Plates 
Boric acid TLC plates were prepared using a slurry of 60 g Silica gel G 
(VWR Canlab, Mississauga, ON, Canada) and 160 mL 0.4 M boric acid to make 
five 20 cm x 20 cm x 0.5 mm thick TLC plates. The plates were allowed to air 
dry then were heated for 2h at 120°C. They were then stored in the presence of 
desiccant until use. 
4.3.11. Analysis of FA Composition 
Tetramethylguanidine was used to transmethylate the lipid samples 
(Shantha et al., 1993; Schuchardt and Lopes, 1988). The lipid samples were 
dried under gaseous N 2 with 2 uL of 20mg C21:0 methyl ester mL'1 added as an 
internal standard. The dried lipid was suspended in 500 uL MeOH: 
Tetramethylguanidine (4:1, v/v) and incubated in boiling water bath for 30min. 
Five milliliters of saturated NaCI solution were added after cooling to room 
temperature, and the lipids were extracted three times with 2 mL of petroleum 
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ether. The extracts were combined and passed over anhydrous Na2S04. The 
lipid extract was evaporated to dryness under N 2 and redissolved in 100 uL 
hexane. FA analysis was carried out as described by Mir et al., (1999) on a 
Supelcowax-10,30 m x 0.25 mm x 0,25um column (Sigma Aldrich Canada, 
Oakville, ON, Canada) installed in an HP5890 Series Plus II gas chromatograph 
equipped with a flame ionization detector and splitless injection. The initial 
temperature was 50°C. This was increased to 200°C at a rate of 25°C per 
minute. Following this the temperature was then increased, sequentially, from 
200°C to 220°C and 220°C to 240°C at a rate of 1°C per min and 15°C per min, 
respectively. Identification of FAs was by comparison to retention times of known 
standards (Sigma Aldrich Canada, Oakville, ON, Canada) and the peaks were 
quatifted based on the area under each peak. Percentages of FAs were 
calculated from the total of the peaks in the chromatogram. Gas liquid 
chromatography peaks for all CLA isomers were pooled and reported as a 
percentage of the total FA composition. 
4.3.12. Calculations and Statistical Analysis 
The FA composition of the sn-1/3 positions of the TAG was calculated 
from the mean values obtained from the TAG (combined sn-1, sn-2 and sn-3), 
and 2- MAG (sn-2) FA analysis as follows. 
sn-1/3% = (TAG% x 3 - 2-MAG%) / 2 (Kagawa ef al., 1996) 
The FA composition of the liver PL sn-2 position was calculated from the 
mean values obtained from the PL (combined sn-1 and sn-2) and LPA (sn-1) 
analysis. 
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sn-2% = PL%x2-LPA% 
FA composition data was analyzed using the JMP IN statistical package 
(Statistical Analysis Systems Institute Inc., 1989 -1997) using a Dunnett's test to 
compare the results of control diets versus diets supplemented with pre-formed 
CLA and results of control diets versus diets supplemented with safflower oil. 
4.4. Results 
4.4.1. FA Composition of TAG from Diaphragm. Rib and SC Fat 
The FA compositions of the TAG fractions of diaphragm, rib and SC fat 
are shown in Tables 1, and 3. In general, regardless of diet, oleic acid (18:1) 
was the major component of the TAG (47.6% - 57.4%) in these three tissues. 
This was followed by palmitic acid (16:0) (23.0% - 30.9%), stearic acid (18:0) 
(8.8% -18.8%), 18:2 (4.4% - 6.1%), CLA (0.2% -1.5%) and, oc-Hnolenic acid 
(18:3) (0.5% -1.2%). The cis 9, trans 11 isomer was the predominant form of 
CLA in all cases. The proportion of CLA present in the TAG of the safflower fed 
animals was significantly higher (P < 0.05) than in the control in all three tissues. 
No significant change in the CLA content of TAG was observed in the tissues of 
the CLA supplemented group in comparison to control. The CLA content of the 
TAG fraction of the diaphragm increased by more than 2.5-fold in animals 
receiving the safflower oil dietary treatment (Table 1), increasing from 0.3% in the 
control group to 0.8% in safflower oil fed group. The CLA content of the TAG 
fraction of the rib increased by the same amount in animals receiving the 
safflower oil dietary treatment (Table 2). There was a significant (P < 0.05) 
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decrease in the percentage of 16:0 and «-18:3 present in the TAG from the rib 
tissue of safflower oil fed animals (Table 2). The proportion of 16:0 in the rib 
TAG decreased from 29.4% in the control group to 25.7% in safflower oil fed 
animals whereas 18:3 decreased from 1.0% of the TAG in the control to 0.5% of 
the TAG FAs in the safflower oil fed group. The decrease in content of these two 
FAs was not observed in the TAGs of the diaphragm and SC fat indicating that 
the effect of safflower oil supplementation on FA composition of TAG may be 
tissue or fat depot specific. The CLA content of the TAG of the SC fat increased 
in the TAG from the safflower oil fed group, from 0.5% in the control to 1.5% in 
the safflower oil fed animals (Table 3). In SC fat TAG, the percentage of 18:0 
was lower than in other tissues, ranging from 8.8% -10.7%, versus 17.1% -
18.8% observed in diaphragm TAG (Table 1) and 25.7% - 30.9% observed in rib 
TAG (Table 2). The percentage of 18:1 in subcutaneous fat TAG (Table 3) was 
slightly higher than in other tissues ranging from 55.1% - 57.4%, versus 48.7 % -
52.3% in diaphragm TAG (Table 1) and 47.6% - 49.1% in rib TAG (Table 2). 
4.4.2. Positional Distribution of FAs in TAG from Diaphragm. Rib and SC Fat 
The FA composition of the sn-2 and sn-1/3 positions of diaphragm, rib and 
SC fat TAG as determined by pancreatic lipase digestion are shown in Tables 1-
3. No significant differences in the proportions of FAs in the sn-2 position of TAG 
from the diaphragm, rib or SC fat were seen as a result of pancreatic lipase 
digestion of TAG. Digestion of TAG with pancreatic lipase determined that CLA 
was more abundant in sn-1/3 positions of TAG than in the sn-2 position. The 
proportion of CLA detected at the sn-2 position was 0.2% or lower in ail 
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categories with the exception of SC fat where the proportion of CLA in the sn-2 
position was 2.3% (Table 3). The proportion of CLA present in the sn-1 /3 
positions of TAG from the three tissues of lambs that were fed with diet 
supplemented with safflower oil was significantly higher (P < 0.05) than in sn-1/3 
positions of TAG from controls. The FA composition at the sn-2 position of TAG 
differed between the lipid extracted from the two muscle tissues (diaphragm and 
rib) and the lipid extracted from SC fat. 
In the sn-2 position of the TAG from the diaphragm, the most abundant FA 
was 18:1 comprising 40.2% - 53.6% of the FAs at that position (Table 1). Oleic 
acid was also the most abundant FA in the sn-1/3 position comprising 51.4% -
58.0% of the combined sn-1 and sn-3 FAs. The percentages of 18:2 detected in 
the sn-2 position ranged from 6.6% - 7.8% whereas the combined percentage for 
the sn-1/3 positions range from 2.7% to 4.7%. Almost no CLA was observed in 
the sn-2 position of the diaphragm TAG, with the exception of the control where 
CLA was detected at 0.15%. The proportion of CLA in the sn-1/3 positions of 
TAG increased 4-fold from 0.3% in control animals to 1.2% the safflower oil fed 
group. 
In the TAG from the rib, 18:1 was the most abundant FA in the sn-2 
position (43.2% - 45.0%) (Table 2). It was also the most abundant FA in the 
combined sn-1 and sn-3 positions (49.1% - 52.5%). The percentage of 18:2 
detected in the sn-2 position ranged from 4.3% to 7.0 %. The value for the 
combined sn-1 and sn-3 positions was 3.6% - 6.4%. CLA was detected in the 
sn-2 position of TAG from rib in the animals on the control and safflower oil 
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supplemented diets at a level of 0.2%. In the sn-1/3 positions of TAG, the CLA 
content was significantly increased (P < 0.05) in the safflower oil supplemented 
animals (from 0.3% for rib controls to 1.1% in rib from animals that received 
safflower supplemented diets). 
The most abundant FA in the sn-2 position of TAG from SC fat tissue was 
18:1, which ranged from 60.4% in the safflower oil supplemented animals to 
71.3% in the CLA supplemented animals (Table 3). CLA was detected in the sn-
2 position of the SC fat tissue TAG from the CLA supplemented animals at 2.3% 
of the total FA at that position. The combined sn-1/3 CLA content was 2.2%, 
which was significantly higher (P < 0.05) than the 0.7% detected in the TAG from 
the control group. 
4.4.3. FA Composition of PL from Diaphragm. Rib. SC Fat and Liver 
The FA composition of PL was different for all the tissues studied but no 
dietary effect was observed. CLA was present in the PL of diaphragm, rib, SC fat 
and liver, but there was no significant change in the distribution of this FA within 
each tissue due to diet (Tables 4 and 5). The major FA of diaphragm PL was 
18:2 (32.9% - 43.6%). The CLA content in the diaphragm was lower than in any 
of the other tissue PLs ranging from 0% - 0.03% (Table 4). The major FAs of rib 
PL were 18:1 (25.8% - 35.2%) and 18:2 (24.5% - 44.6%). The CLA content of rib 
PL ranged from 0.05% -1.8% (Table 4). The major FA of SC fat PL was 18:1 
(48.8% - 55.5%). The CLA content of SC fat PL ranged from 1.0% -1.1 %. The 
percentage of 18:2 present was the lowest of all tissues studied at 6.2% -10.9% 
(Table 4). The most abundant FAs of liver PL were 18:1 (25.6% - 27%) and 18:0 
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(30.8% - 33.4%). The CLA content of liver PL ranged from 0.05% - 2.9% (Table 
5). 
4.4.4. Positional Distribution of FAs in Liver PL 
Phospholipase A 2 digestion of liver PL determined CLA was present in the 
sn-2 position of the liver PL (Table 5). The sn-1 position of liver PL had a higher 
proportion of 16:0 (28.2% - 31.4%) than the sn-2 position (7.3% -13.2%). The 
sn-2 position of liver PL had a higher proportion of 18:1 (36.3% - 38.2%) than the 
sn-1 position (13.0% - 23.6%) of liver PL. 
4.5. Discussion 
Basal diets supplemented by unprotected polyunsaturated fats in 
vegetable oils have been shown to have little effect on FA composition of 
adipose tissue and skeletal muscle sampled from various sites in steers (Christie, 
1979). For example, Christie's work showed that supplementation with 6% 
safflower oil only resulted in a slight increase in the proportion of 16:0 and 18:0. 
Because dietary lipids are extensively hydrogenated in the rumen to produce 
saturated FAs, incorporation of higher levels of polyunsaturated fats in ruminant 
tissues is usually accomplished by the feeding of protected feed supplements 
that pass through the rumen and are absorbed in the small intestine unchanged. 
The 18:2 present in safflower oil is biohydrogenated in the rumen to ultimately 
produce 18:0. Intermediates of the biohydrogenation of 18:2 are CLAs (Kepler et 
a/., 1966). In the current study, lambs fed a diet supplemented by 6% safflower 
oil showed a significant increase (P < 0.05) in the proportion of CLA in the TAG 
57 
fraction of diaphragm, SC fat and rib but no significant change in the content of 
other major FA components was observed. In section 3 of this thesis, increases 
of 2- to 4-fold in the CLA content of TL of tissues were reported for lambs fed a 
diet supplemented with 6% safflower oil (Mir ef a/., 2000). 
The polyunsaturated fat content in tissues of young ruminants has been 
shown to increase following feeding with milk replacers supplemented with 12.5 -
70 g d " 1 of sunflower oil for up to sixteen weeks (Christie, 1979). The analysis of 
the muscle and adipose tissue fats by Christie from animals on this 
supplemented diet contained up to 40% of 18:2 in the TAG fraction after 30 d. 
This increase in 18:2 content was accomplished due to the bypass of the rumen 
when the esophageal groove was closed while suckling. In this way, the 
components of the diet were absorbed in the small intestines as in non-
ruminants. In the current study, the direct feeding of CLA to pre-weaned lambs 
for 21 d prior to weaning did not increase the CLA content of the TAG fraction of 
any of the tissues studied. The CLA may have been metabolized for energy by 
the growing lambs. The increased CLA content observed in the TAG of the 
animals receiving the safflower diet resulted in incorporation and storage of CLA 
in the TAG fraction of diaphragm, SC fat and rib of lambs. The higher proportion 
of CLA in the TAG of the SC fat, which was 2-fold that of diaphragm or rib, 
suggested that CLA was preferentially stored in SC fat. 
In mammalian fat depots, unsaturated FAs have a tendency to be 
localized to the sn-2 position of TAG whereas saturated FAs tend to be localized 
to the sn-1 and sn-3 positions (Brokerhoff ef a/., 1966). Changes in FA positional 
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distribution as affected by diet have been shown in bovine and ovine adipose 
tissues (Hawke etai, 1977; Mills etai, 1975; Smith etai, 1998) and ovine liver 
(Mills etai, 1975), but the mechanism responsible for these dietary induced 
changes is unknown. In previous studies, high proportions of additional 18:2, 
due to protected supplement feeding, incorporated into adipose tissues of 
ruminants were preferentially esterified to the sn-2 position and to a lesser extent 
the sn-3 position (Christie, 1979; Mills ef al., 1975). In the current study, the 
diaphragm, rib and SC fat TAG positional distribution analysis showed an 
increased proportion of CLA in the sn-1/3 position in the safflower diet group 
suggesting that lysophosphatidate acyltransferase in these tissues had a 
decreased preference for CLA moieties compared to other fatty acyl moieties. 
Lysophosphatidate acyltransferase (EC 2.3.1.51) catalyzes the acyl-CoA 
dependent acylation of LPA to generate phosphatidate (Lehner and Kuksis, 
1996). In contrast, CLA was detected in the sn-2 position of TAG of SC fat from 
the CLA supplemented animals. This observation indicated that the feeding of 
CLA pre-weaning might have had an effect on the placement of the CLA on TAG 
from SC fat. 
Previous studies on incorporation of CLA have shown that CLA is readily 
incorporated into the PL fraction of the mammary gland and forestomach tissues 
of rodents (Ha ef a/., 1990; Ip ef a/., 1991). There is also evidence that CLA is 
preferentially incorporated into the NL fraction (Belury ef a/., 1996). In the current 
study, safflower supplementation in the diet had no effect on the CLA content of 
PL from diaphragm, rib and SC fat tissue suggesting that CLA was preferentially 
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incorporated into the TAG of these tissues. The lack of change in the FA 
composition of the PL fraction as a function of dietary manipulation indicated that 
there may be a threshold of CLA incorporation into the PL of ruminants. Belury 
ef al. suggested that the biological activity of CLA might be more related to 
deposition of fat rather than through effects on PL alteration. The low levels of 
X-18:3 in the PL of rib, liver and SC fat may be due to the competitive 
metabolism of CLA versus 18:2 to produce a conjugated form of 18:3 (Banni ef 
a/., 1996), which was not quantified in this study. Banni ef al. detected the 
intermediates of CLA elongation and desaturation incorporated into liver PLs 
along with the end product, conjugated arachidonic acid. 
Tissue PLs have a characteristic positional distribution of FAs as in tissue 
TAGs. In general, saturated and unsaturated FAs of PL are located at the sn-1 
and sn-2 position, respectively (Mills et al., 1975). The results from the current 
study conformed to this trend. 
In conclusion, supplementation of lamb feedlot diet with safflower oil as a 
source of unprotected 18:2 resulted in a significant increase in the CLA content 
of TAG of various tissues. Dietary manipulation had no significant effect on the 
CLA content of the PL suggesting that the FA isomers were preferentially 
incorporated into TAG. The highest proportions of CLA were observed in SC fat 
indicating that CLA was preferentially stored in this fat depot. CLA was not 
detected in any tissues examined in significant quantities at the sn-2 position of 
the TAG molecule. There was, however, an increased amount CLA in the sn-2 
position of the SC fat from animals supplemented with pre-formed CLA. 
Although CLA feeding pre-weaning had no effect on the total CLA content of the 
TAG, it influenced the positional distribution of CLA on the TAG molecule. CLA 
was exclusively localized to the sn-2 position of PL from liver under all dietary 
regimes. Studies on the specificity and selectivity for CLA of the 
acyltransferases involved in TAG bioassembly should provide further insight into 
the mechanism of CLA incorporation into glycerolipids. 
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Table 1 
Patty acid (wt.%) 
Fraction Diet 16:0 18:0 18:1 18:2 18:3 CLA n 
TAG 
CLA 24.9 17.1 52.1 4.4 1.0 0.4 3 
Control 23.0 18.8 52.3 4.8 0.8 0.3 5 
Safflower 26.2 17.5 48.7 5.8 0.9 *0.8 4 
SEM 1.10 0.91 1.02 0.27 0.22 0.04 
sn-2 
CLA 28.1 23.8 40.2 7.8 0.0 0.0 3 
Control 20.8 18.6 53.6 6.6 0.16 0.15 5 
Safflower 26.1 22.7 43.2 8.0 0.0 0.0 4 
SEM 1.89 1.77 2.96 1.72 0.07 0.06 
sn-1/3 
CLA 23.4 13.9 58.0 2.7 1.5 0.5 3 
Control 24.1 18.8 51.6 3.9 1.1 0.3 5 
Safflower 26.2 14.9 51.4 4.7 1.4 *1.2 4 
SEM 1.86 1.74 2.01 0.98 0.32 0.07 
*P < 0.05 by Dunnetf s test compared to control. 
CLA, CLA in diet as free acid pre-weaning; safflower, 6% safflower oil in diet 
post-weaning; control, no dietary treatment; SEM, standard error of the mean. 
Effect of diet on FA composition of TAG and positional distribution of 
FAs in TAG from diaphragm. 
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Table 2 
Fatty acid (wt.%) 
Fraction Diet 16:0 18:0 18:1 18:2 18:3 CLA n 
TAG 
CLA 30.9 15.3 47.6 4.7 1.2 0.2 4 
Control 29.4 16.8 47.7 4.8 1.0 0.3 5 
Safflower •25.7 18.2 49.1 5.7 #0.5 •0.8 4 
SEM 0.83 0.89 0.45 0.45 0.09 0.04 
sn-2 
CLA 27.5 22.3 43.2 7.0 0.0 0.0 4 
Control 29.1 22.4 45.0 3.1 0.15 0.2 5 
Safflower 28.7 24.7 42.1 4.3 0.0 0.2 4 
SEM 2.04 2.89 2.93 1.59 0.06 0.14 
sn-1/3 
CLA 32.7 11.8 49.9 3.6 1.7 0.3 4 
Control 29.6 14.1 49.1 5.6 1.3 0.3 5 
Safflower 
SEM 
24.2 
2.05 
15.0 
1.84 
52.5 
2.12 
6.4 
1.20 
•0.8 
0.14 
•1.1 
0.08 
4 
*P < 0.05 by Dunnett's test compared to control. 
CLA, CLA in diet as free acid pre-weaning; safflower, 6% safflower oil in diet 
post-weaning; control, no dietary treatment; SEM, standard error of the mean. 
The effect of diet on FA composition of TAG and positional distribution of 
FAs in TAG from rib. 
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Table 3 
Fatty Acid (wt.%) 
Fraction Diet 16:0 18:0 18:1 18:2 18:3 CLA n 
TAG 
CLA 28.8 9.8 55.1 4.2 0.7 0.5 4 
Control 25.5 10.7 57.4 5.1 0.8 0.5 5 
Safflower 27.9 8.8 55.1 6.1 0.7 *1.5 4 
SEM 1.29 1.11 2.05 0.59 0.08 0.13 
sn-2 
CLA 12.3 8.2 71.3 5.0 1.0 2.3 4 
Control 15.3 9.7 67.1 7.9 0.0 0.0 5 
Safflower 20.9 15.3 60.4 3.3 0.0 0.0 4 
SEM 2.14 1.67 3.10 1.24 0.30 0.70 
sn-1/3 
CLA 37.0 10.6 48.4 3.8 0.6 •-0.4 4 
Control 30.5 11.2 52.5 3.8 1.3 0.7 5 
Safflower 31.4 5.5 52.4 7.4 1.0 •2.2 4 
SEM 2.04 1.97 3.09 0.93 0.26 0.46 
*P< 0.05 by Dunnetfs test compared to control; 
•Negative value due to low abundance of PA. 
CLA, CLA in diet as free acid pre-weaning; safflower, 6% safflower oil in diet 
post-weaning; control, no dietary treatment; SEM, standard error of the mean. 
The effect of diet on FA composition of TAG and positional distribution of 
FAs in TAG from SC fat 
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Table 4 
The effect of diet on FA composition of PL from diaphragm, rib and SC fat. 
Fraction Diet 
Diaphragm 
Rib 
SCfat 
Safflower 
SEM 
CLA 
Control 
Safflower 
SEM 
CLA 
Control 
Safflower 
SEM 
20.5 
14.2 
23.8 
26.2 
Fatty Acid (wt.%) 
16:0 18:0 18:1 18:2 18:3 CLA n 
CLA 18.2 24.2 22.9 32.9 1.8 0.01 
Control 16.3 25.7 21.2 35.1 1.6 0.03 
12.8 26.6 16.2 43.6 0.7 0.00 
1.33 1.11 1.68 2.70 0.16 0.01 
23.8 14.0 35.2 24.5 
15.3 34.0 
12.8 25.8 
26.6 
44.6 
2.5 
2.3 
0.9 
1.60 1.49 3.10 5.13 
17.5 48.8 
19.0 46.8 
8.4 
6.2 
0.4 
0.6 
0.05 
1.2 
1.8 
0.20 0.55 
1.1 
1.1 
18.3 14.1 55.5 10.9 0.2 1.0 4 
2.87 2.04 4.91 2.37 0.19 0.51 
*P < 0.05 by Ounnetts test compared to control. 
CLA, CLA in diet as free acid pre-weaning; safflower, 6% safflower oil in diet 
post-weaning; control, no dietary treatment; SEM, standard error of the mean. 
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Table 5 
Fatty Acid (wt.%) 
Tissue Diet 16:0 18:0 18:1 18:2 18:3 CLA n 
PL 
CLA 22.3 33.4 27.0 14.7 2.0 0.5 4 
Control 22.5 32.0 25.6 15.2 1.8 2.9 5 
Safflower 17.8 30.8 30.0 18.2 0.6 2.6 4 
SEM 1.44 1.74 0.76 1.95 0.23 1.36 
sn-1 
CLA 31.4 33.1 16.8 16.9 1.8 0.0 4 
Control 29.8 29.3 13.0 26.4 1.5 0.0 5 
Safflower 28.2 24.7 23.6 23.2 0.3 0.0 4 
SEM 2.55 4.06 4.23 3.79 0.33 0.0 
sn-2 
CLA 13.2 33.7 37.2 12.6 2.2 1.0 4 
Control 15.2 34.7 38.2 4.0 2.1 5.7 5 
Safflower 7.3 37.0 36.3 13.2 0.9 5.3 4 
SEM 4.1 3.8 4.7 3.6 0.4 2.7 
*P < 0.05 by Dunnetfs test compared to control. 
CLA, CLA in diet as free acid pre-weaning; safflower, 6% safflower oil in diet 
post-weaning; control, no dietary treatment; SEM, standard error of the mean. 
The effect of diet on FA composition of PL and positional distribution of 
FAs in PL from liver. 
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5. Summary and Future Directions. 
In this study, lambs were supplemented with CLA at a rate of 0.33g CLA 
day"1 for 21 days prior to weaning or with a rich source of linoleic acid (6% 
safflower oil) in their diet after weaning until a slaughter weight of 45kg was 
reached. Supplementation of lamb diets with a rich source of linoleic acid 
resulted in significant increases (P < 0.05) in the amount of CLA in the TL and 
TAG of tissues when compared with that of animals fed the unsupplemented 
control diet. The CLA content of the TL or TAG was not affected in any of the 
tissues examined from lambs fed CLA-supplemented milk replacer prior to 
weaning. Digestion of TAG with pancreatic lipase determined that CLA is more 
abundant in sn-1/3 positions of TAG than in the sn-2 position. Dietary 
manipulation had no significant effect on the CLA content of the PL fraction of the 
TL. Determination of the positional distribution of FA on the liver PL indicated 
that CLA is localized to the sn-2 position of liver PL. 
Development of methods to increase CLA content in the carcass of 
ruminants will enhance the nutraceutical value of meat products. The described 
research on dietary manipulation of CLA in sheep is a step in this direction. The 
effect of diet in promoting CLA incorporation into meat should also be examined 
in beef cattle. The dietary effects of increased LA in the diet on rumen function, 
bacterial biohydrogenation processes and CLA incorporation should be 
examined to determine optimal dietary regimes. Further investigation into the 
positional distribution of CLA on the TAG should be examined in ruminants to 
67 
determine the distribution of CLA between the sn-1 and sn-3 positions. The 
positional distribution of CLA on PL of tissues other than the liver should be 
carried out to determine, for comparative purposes, if the same positional 
distribution pattern of FA does exist in other tissue. To extend the knowledge of 
positional distribution of CLA as a group of isomers it would be useful to 
determine the presence, quantities and locations of individual isomers of CLA on 
TAG and PL. It would also be useful to examine the specificity and selectivity for 
CLA moieities by acyltransferases involved in the synthesis of TAG and whether 
or not there are tissue specific differences in enzyme action. As well, it would be 
useful to study possible differences in specificity and selectivity of 
acyltransferases for CLA isomers. In addition, the possible modulatory effects of 
CLA and individual CLA isomers on acyltransferases could be investigated. A 
detailed understanding of the regulation of TAG biosynthesis in relation to diet in 
ruminants will provide useful information of the development of a value added 
meat product. 
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